glucose levels in cows after calving receiving the CRC were increased 15%. Another Canadian study reported a 40 % reduction in both clinical ketosis and DA's. Retained placenta were numerically lower for cows fed Rumensin. It was reported that body condition score (BCS) had an impact on milk production response. Cows classified as thin (BCS

Rumensin is commonly used for feedlot cattle. Presumably, this is related to ancillary benefits on acidosis control and controlling intake on high-grain diets (much of the data on Rumensin has been collected at the University of Nebraska with finishing cattle and acidosis).

monensin (Rumensin®) and lasalocid (Bovatec®) are ap­ proved for beef cattle. Laidlomycin ( Cattlyst®) is expected to be approved by spring of 1994. Monensin and lasalocid are approved coccidiostats in cattle. Monensin Monensin is marketed by Elanco Products Com­ pany, a division of Eli Lilly and Company under the trade name Rumensin®.

Rumensin is registered for improved weight gain and feed efficiency in cattle and sheep, improved reproductive performance in heifers and as an aid in the prevention of coccidiosis in cattle, sheep, goats and chickens.
Rumensin® for Beef Cattle For over 45 years, producers have trusted Elanco's Rumensin® to deliver consistent, dependable results that add more profit potential to the bottom line. The findings from more than 400 Elanco research studies have made it possible for producers to include Rumensin in ever-changing feed programs and management systems. . 741 444 29 40 211 187 236 635

what is rumensin for cattle